Biomerica (BMRA) FCF Margin Growth (5y) (2015 - 2026)
Biomerica (BMRA) FCF Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Biomerica | 4.85 Mn | 3.51 Mn | -44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -8,782.00 |
| Nov 30, 2025 | 1,318.00 |
| Aug 31, 2025 | 12,368.00 |
| May 31, 2025 | 4,021.00 |
| Feb 28, 2025 | -5,444.00 |
| Nov 30, 2024 | -2,567.00 |
| Aug 31, 2024 | -7,351.00 |
| May 31, 2024 | -868.00 |
| Feb 29, 2024 | -15,516.00 |
| Nov 30, 2023 | -3,683.00 |
| Aug 31, 2023 | -3,651.00 |
| May 31, 2023 | -5,347.00 |
| Feb 28, 2023 | -11,872.00 |
| Nov 30, 2022 | -6,664.00 |
| Aug 31, 2022 | -8,815.00 |
| May 31, 2022 | -5,771.00 |
| Feb 28, 2022 | 4,071.00 |
| Nov 30, 2021 | -4,579.00 |
| Aug 31, 2021 | 1,070.00 |
| May 31, 2021 | -9,570.00 |